Clinical Trial Update: Effect of Empagliflozin on Body Composition and Ketones [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effects of empagliflozin on body composition and ketone levels.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Diabetes Mellitus, Fat; Intolerance, Pancreas | Phase 4 | Status: UNKNOWN